Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition
โ Scribed by Terry M. Therneau; Robert A. Kyle; L. Joseph Melton III; Dirk R. Larson; Joanne T. Benson; Colin L. Colby; Angela Dispenzieri; Shaji Kumar; Jerry A. Katzmann; James R. Cerhan; S. Vincent Rajkumar
- Book ID
- 119323300
- Publisher
- Mayo Clinic
- Year
- 2012
- Tongue
- English
- Weight
- 535 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0025-6196
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Venous thromboembolic disease (vtd) is a recently recognized complication of thalidomide in combination therapy for patients with multiple myeloma (mm). the authors assessed the frequency of vtd and its risk factors in 612 consecutive patients with plasma cell dyscrasia (pcd) who wer
A number of common disorders of the peripheral nervous system are closely linked to a monoclonal gammopathy. In a minority of patients, the neuropathy represents the sentinel feature of a malignant plasma cell dyscrasia, such as multiple myeloma or its osteosclerotic variant, Waldenstrom's disease,